[split] Dimethylfumarates and Psoriasis

[jiml]

Apart from us normal people there are a number of very vague institutions in Europe that must be crowded with people who decide over our well being. That is weird and scary as "WE" are the real professionals on psoriasis... Aren't we?

If you read, or try to read, this article [web]https://www.clinicaltrialsregister.eu/ctr-search/trial/2012-000055-13/DE[/web] you will get an idea of what I mean.
Lots of people are involved in trials which concern our health, but of which we don't have a clue of what is happening there.
This case is about DMF and Fumaderm.
Rumours say that Almiral, the producer of Fumaderm, is close to a European wide registration of Fumaderm.
Psorinovo is far behind in this process, while it's characteristics may even be better and the working substances are equal.
Also Rumours are that biogen is trying to interfere in some way in the DMF market.
Overall interest in DMF is rising quickly. In my opinion due to the fact that biog** has seen and opportunity to earn a lot of money with it over the backs of the MS patients.

Heavy reading indeed... I have added to my reading list and will read it late tonight. So will comment after reading, it looks very difficult to understand.